Search Results - "Procyshyn, Ric M."

Refine Results
  1. 1

    Long-acting injectable antipsychotics for early psychosis: A comprehensive systematic review by Lian, Lulu, Kim, David D, Procyshyn, Ric M, Cázares, Diana, Honer, William G, Barr, Alasdair M

    Published in PloS one (29-04-2022)
    “…Long acting injectable (LAI) antipsychotics are an alternative to oral antipsychotic (OAP) treatment and may be beneficial for patients in the early stages of…”
    Get full text
    Journal Article
  2. 2

    A comparison of the metabolic side-effects of the second-generation antipsychotic drugs risperidone and paliperidone in animal models by Boyda, Heidi N, Procyshyn, Ric M, Tse, Lurdes, Yuen, Jessica W Y, Honer, William G, Barr, Alasdair M

    Published in PloS one (28-01-2021)
    “…The second generation antipsychotic drugs represent the most common form of pharmacotherapy for schizophrenia disorders. It is now well established that most…”
    Get full text
    Journal Article
  3. 3

    Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review by Yin, John, Barr, Alasdair M, Ramos-Miguel, Alfredo, Procyshyn, Ric M

    Published in Current neuropharmacology (01-01-2017)
    “…Chronic prescription of antipsychotics seems to lose its therapeutic benefits in the prevention of recurring psychotic symptoms. In many instances, the…”
    Get full text
    Journal Article
  4. 4

    A Focused Review of the Metabolic Side-Effects of Clozapine by Yuen, Jessica W Y, Kim, David D, Procyshyn, Ric M, Panenka, William J, Honer, William G, Barr, Alasdair M

    Published in Frontiers in endocrinology (Lausanne) (25-02-2021)
    “…The second generation antipsychotic drug clozapine represents the most effective pharmacotherapy for treatment-resistant psychosis. It is also associated with…”
    Get full text
    Journal Article
  5. 5

    Cardiovascular side-effects of antipsychotic drugs: the role of the autonomic nervous system by Leung, Joanne Y T, Barr, Alasdair M, Procyshyn, Ric M, Honer, William G, Pang, Catherine C Y

    Published in Pharmacology & therapeutics (Oxford) (01-08-2012)
    “…Cardiovascular disease is the leading cause of death in people with severe mental disorders, and rates are proportionally greater than for other diseases such…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Preclinical models of antipsychotic drug-induced metabolic side effects by Boyda, Heidi N, Tse, Lurdes, Procyshyn, Ric M, Honer, William G, Barr, Alasdair M

    “…Antipsychotic drugs (APDs), and the ‘atypical’ APDs in particular, are commonly associated with metabolic side effects in humans. These include glucose…”
    Get full text
    Journal Article
  8. 8

    Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review by Yuen, Jessica W Y, Kim, David D, Procyshyn, Ric M, White, Randall F, Honer, William G, Barr, Alasdair M

    Published in Frontiers in neuroscience (04-04-2018)
    “…Clozapine is the antipsychotic of choice for treatment-resistant schizophrenia and has minimal risk for extrapyramidal symptoms. Therapeutic benefits, however,…”
    Get full text
    Journal Article
  9. 9

    Antipsychotic prescribing patterns on admission to and at discharge from a tertiary care program for treatment-resistant psychosis by Lee, Lik Hang N, Procyshyn, Ric M, White, Randall F, Woodward, Todd S, Honer, William G, Barr, Alasdair M

    Published in PloS one (10-08-2018)
    “…Retrospective data were collected from 330 individuals who were treated at a tertiary care program for treatment-resistant psychosis between 1994 and 2010. The…”
    Get full text
    Journal Article
  10. 10

    Association between Serum Lipids and Antipsychotic Response in Schizophrenia by Kim, David D, Barr, Alasdair M, Fredrikson, Diane H, Honer, William G, Procyshyn, Ric M

    Published in Current neuropharmacology (01-01-2019)
    “…Metabolic abnormalities are serious health problems in individuals with schizophrenia. Paradoxically, studies have noted an association where individuals who…”
    Get full text
    Journal Article
  11. 11

    Developing prediction models for symptom severity around the time of discharge from a tertiary-care program for treatment-resistant psychosis by Lee, Lik Hang N, Procyshyn, Ric M, White, Randall F, Gicas, Kristina M, Honer, William G, Barr, Alasdair M

    Published in Frontiers in psychiatry (07-06-2023)
    “…Antipsychotics are the only therapeutic class indicated in the symptomatic management of psychotic disorders. However, individuals diagnosed with schizophrenia…”
    Get full text
    Journal Article
  12. 12

    Differential Effects of Acute Treatment With Antipsychotic Drugs on Peripheral Catecholamines by Boyda, Heidi N, Ho, Amanzo A, Tse, Lurdes, Procyshyn, Ric M, Yuen, Jessica W Y, Kim, David D, Honer, William G, Barr, Alasdair M

    Published in Frontiers in psychiatry (01-12-2020)
    “…Antipsychotic drugs represent the most effective treatment for chronic psychotic disorders. The newer second generation drugs offer the advantage of fewer…”
    Get full text
    Journal Article
  13. 13

    Characterization of mental health in cannabis dispensary users, using structured clinical interviews and standardized assessment instruments by Yau, Jade C, Yu, Shu Min, Panenka, William J, Pearce, Hadley, Gicas, Kristina M, Procyshyn, Ric M, MacCallum, Caroline, Honer, William G, Barr, Alasdair M

    Published in BMC psychiatry (01-11-2019)
    “…Cannabis is commonly used for its medical properties. In particular, cannabis is purported to have beneficial effects on a wide range of neuropsychiatric…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Antipsychotic Drug-Induced Increases in Peripheral Catecholamines are Associated With Glucose Intolerance by Boyda, Heidi N, Pham, Michelle, Huang, Joyce, Ho, Amanzo A, Procyshyn, Ric M, Yuen, Jessica W Y, Honer, William G, Barr, Alasdair M

    Published in Frontiers in pharmacology (15-02-2022)
    “…The second-generation antipsychotic drugs are widely used in the field of psychiatry, for an expanding number of different conditions. While their clinical…”
    Get full text
    Journal Article
  16. 16

    Antipsychotic-Associated Symptoms of Tourette Syndrome: A Systematic Review by Kim, David D., Barr, Alasdair M., Chung, Yunsun, Yuen, Jessica W. Y., Etminan, Mahyar, Carleton, Bruce C., White, Randall F., Honer, William G., Procyshyn, Ric M.

    Published in CNS drugs (01-10-2018)
    “…Background Although antipsychotics are used to treat Tourette syndrome, there have been reports of paradoxical induction of tics by first- and…”
    Get full text
    Journal Article
  17. 17

    Metabolic side-effects of the novel second-generation antipsychotic drugs asenapine and iloperidone: a comparison with olanzapine by Boyda, Heidi N, Procyshyn, Ric M, Pang, Catherine C Y, Hawkes, Erin, Wong, Daniel, Jin, Chen Helen, Honer, William G, Barr, Alasdair M

    Published in PloS one (09-01-2013)
    “…The second generation antipsychotic (SGA) drugs are widely used in psychiatry due to their clinical efficacy and low incidence of neurological side-effects…”
    Get full text
    Journal Article
  18. 18

    Need for Bioequivalence Standards that Reflect the Clinical Importance of the Complex Pharmacokinetics of Paliperidone Palmitate Long-Acting Injectable Suspension by Procyshyn, Ric M, Lamoure, Joel W, Katzman, Martin A, Skinner, Pamela L, Sherman, Stephen E

    “…Paliperidone palmitate is a second generation antipsychotic, approved for the treatment of schizophrenia in the form of the long-acting injectable (LAI)…”
    Get full text
    Journal Article
  19. 19
  20. 20

    A systematic review of the effects of CYP2D6 phenotypes on risperidone treatment in children and adolescents by Dodsworth, Thomas, Kim, David D, Procyshyn, Ric M, Ross, Colin J, Honer, William G, Barr, Alasdair M

    “…The second generation antipsychotic drug risperidone is widely used in the field of child and adolescent psychiatry to treat conditions associated with…”
    Get full text
    Journal Article